Trial intelligence / Profile preview

Hexaminolevulinate Imaging in Colon Neoplasia

NCT01344902Phase 2Terminated

Sponsor
Photocure
Start
Feb 2009
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hexaminolevulinate in colonic neoplasms (CRC), sponsored by Photocure. Started Feb 2009; status: terminated.

02

Drugs

hexaminolevulinate
03

Conditions

colonic neoplasms (CRC)

Beyond the preview

Go deeper on NCT01344902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01344902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call